MDGL
USDMadrigal Pharmaceuticals Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$488.030
Máximo
$494.550
Mínimo
$477.000
Volumen
0.76M
Fundamentos de la Empresa
Capitalización de Mercado
11.1B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.37M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
B of A Securities Upgrades Madrigal Pharmaceuticals to Neutral, Raises Price Target to $445
B of A Securities analyst Alexandria Hammond upgrades Madrigal Pharmaceuticals from Underperform to Neutral and raises the price target from $266 to $445.
Madrigal to Present New Data from the Company's MASH Program at AASLD's The Liver Meeting 2025
Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of RezdiffraPoster of distinction examines the
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated
Truist Securities Initiates Coverage On Madrigal Pharmaceuticals with Buy Rating, Announces Price Target of $580
Truist Securities analyst Srikripa Devarakonda initiates coverage on Madrigal Pharmaceuticals with a Buy rating and announces Price Target of $580.
Acciones Relacionadas
FTF
Franklin Limited Duration Income Trust Common Shares of Beneficial Interest
FLWS
1-800-FLOWERS.COM Inc.
ORIC
Oric Pharmaceuticals Inc.
GTHX
G1 Therapeutics Inc.
AWX
Avalon Holdings Corporation
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.